✦ LIBER ✦

Delivery of Engineered Therapeutics and Medication

✍ Scribed by Dong-an Wang

Book ID: 106494228
Publisher: Springer US
Year: 2011
Tongue: English
Weight: 114 KB
Volume: 28
Category: Article
ISSN: 0724-8741
DOI: 10.1007/s11095-011-0439-0

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Engineering Particles for Therapeutic De

Engineering Particles for Therapeutic Delivery: Prospects and Challenges

✍ Yan, Yan; Such, Georgina K.; Johnston, Angus P. R.; Best, James P.; Caruso, Fran 📂 Article 📅 2012 🏛 American Chemical Society 🌐 English ⚖ 370 KB

Delivery of siRNA Therapeutics: Barriers

Delivery of siRNA Therapeutics: Barriers and Carriers

✍ Jie Wang; Ze Lu; M. Guillaume Wientjes; Jessie L.-S. Au 📂 Article 📅 2010 🏛 American Association of Pharmaceutical Scientists 🌐 English ⚖ 384 KB

Natural and engineered ribonucleases as

Natural and engineered ribonucleases as potential cancer therapeutics

✍ Ulrich Arnold; Renate Ulbrich-Hofmann 📂 Article 📅 2006 🏛 Springer Netherlands 🌐 English ⚖ 247 KB

Targeted delivery of therapeutics to end

Targeted delivery of therapeutics to endothelium

✍ Eric Simone; Bi-Sen Ding; Vladimir Muzykantov 📂 Article 📅 2008 🏛 Springer-Verlag 🌐 English ⚖ 445 KB

Delivery of therapeutic proteins

✍ Dipak S. Pisal; Matthew P. Kosloski; Sathy V. Balu-Iyer 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 298 KB

The safety and efficacy of protein therapeutics are limited by three interrelated pharmaceutical issues, in vitro and in vivo instability, immunogenicity and shorter half-lives. Novel drug modifications for overcoming these issues are under investigation and include covalent attachment of poly(ethyl

Macromolecular Synthetic Biomaterials fo

Macromolecular Synthetic Biomaterials for Delivery of Therapeutics

✍ Yi-Yan Yang; Andrew J. T. George; Kazunori Kataoka; Dan Luo; Shu Wang 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 53 KB